Vyleesi® returned to Palatin TechnologiesCompany focuses on optimizing marketed assets and development of its innovative pipelineWALTHAM, Mass., July 27, 2020 […]
ALPHARETTA, Ga., July 27, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments […]
VASCEPA showed significant reduction in coronary revascularization, including coronary stenting and cardiac bypass surgery, in prespecified and post hoc analyses […]
WATERTOWN, Mass., July 27, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing […]